Skip to Content

CLIMAVAL 2MG TABLETS

Active substance(s): ESTRADIOL VALERATE

View full screen / Print PDF » Download PDF ⇩
Transcript
Pg 4

DT

Q.A.
APPROVED:

CUSTOMER
APPROVED:

30/10/12

DATE:

DATE:

CUSTOMER: Waymade

PRE-PRESS NO.:

02-1808

PRODUCT:

climaval 2mg tabs

ARTWORKER:

CODE:

6464/2013G

DATE OF PROOF:

PROOF HISTORY:
v.1 - waymade - 30/10/12

\(ÃEè7
Leaflet Flat Size = 296 x 420
ARIAL REGULAR FONT SIZE 8
ARIAL BOLD FONT SIZE 10
BRIDGED TO
TRANSTEC 6464/2327 2328 2329

UK PIL DATED JANUARY 2012

Pg 1

Pg 4

Like all medicines, this medicine can cause side effects, although not everybody gets them.
Some effects could be serious
These symptoms need immediate medical attention.
• Unexpected vaginal bleeding or spotting (breakthrough bleeding) after taking Climaval for some time,
or after you stop treatment
• Painful menstrual periods
• Painful swelling and redness of the legs
• Sudden chest pain
• Difficulty in breathing
• Pain in your chest that spreads to your arm or neck
• Yellowing of the eyes and face (jaundice)
• Rapid increase in your blood pressure
• Unexplained migraine-like headaches
• Breast changes, including dimpling of the breast skin, changes in the nipple, lumps that you can see
or feel.
Stop taking Climaval and tell your doctor immediately if you get any of the effects mentioned above.
Check the risks to be aware of with HRT in general in section 2, When to take special care with Climaval.
Other side effects
In addition, the following side effects have been reported with Climaval:
• Breast tension and pain, breast cancer.
• Discharge from the vagina.
• Headache, dizziness, vertigo, changes in sexual desire, depression.
• Increased blood pressure, palpitations (sensation of fluttering in the chest), fast heartbeat or other
heart symptoms, tender or painful veins (signs of thrombophlebitis), fluid retention, nose bleeds.
• Indigestion, wind, nausea, vomiting, abdominal pain and bloating, problems with your gall bladder
(biliary stasis).
• General itching, hair loss, hives and skin rash.
• Glucose intolerance which can make you sweat or feel faint after eating.
• Weight gain.
The following side effects have been reported with other HRTs:
• Gall bladder disease
• Various skin disorders:
– discoloration of the skin especially of the face or neck known as “pregnancy patches”
(chloasma)
– painful reddish skin nodules (erythema nodosum),
– rash with target-shaped reddening or sores (erythema multiforme)
• Decline in memory or mental ability
• Diarrhoea
• Migraine,
• Fibroids (benign growths in the uterus)
• Pain in extremity
• Dry eyes and contact lens discomfort
If you get the side effects talk to your doctor or pharmacist. This includes any possible side effects not
listed in this leaflet.

5. How to store Climaval
Keep out of the sight and reach of children.
Do not use Climaval after the expiry date which is printed on the carton or blister label. The expiry date refers
to the last day of that month.
Do not store above 25˚C. Store in a dry place and keep in the original packaging.
Protect from light.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose
of medicines no longer required. These measures will help to protect the environment.
If the tablets become discoloured or show any other signs of deterioration, consult your pharmacist who will
tell you what to do.

6. Contents of the pack and other information
What Climaval contains
Climaval 2mg Tablets contains 2mg of the active ingredient estradiol valerate and is a blue round tablet
marked ‘CG’ on one side and ‘OD’ on the other.
Climaval 2mg Tablets also contains the following:
Lactose, maize starch, povidone, talc, magnesium stearate, hypromellose, propylene glycol, indigo carmine
(E132), titanium dioxide (E171) and purified water.
Climaval 2mg Tablets are available as blister packs of 28 or 3 x 28 tablets.
POM

PL No: 6464/2013

This product is manufactured by Novartis Pharmaceuticals UK Limited, Horsham, West Sussex, UK and is
procured from within the EU and repackaged by the Product Licence holder:
Waymade Plc, Miles Gray Road, Basildon, Essex SS14 3FR.
Leaflet revision and issue date (Ref.) 23.10.2012
Climaval is a registered trademark of NOVARTIS AG

CLIMAVAL® 2mg TABLETS
(estradiol valerate)
Patient Information Leaflet

Your medicine is known by the above name but will be referred to as Climaval throughout this leaflet. Another
strength (1mg) is also available.
Read all of this leaflet carefully before you start taking this medicine because it contains important
information for you.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor or pharmacist.

This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even
if their signs of illness are the same as yours.

If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects
not listed in this leaflet.
In this leaflet:
1. What Climaval is and what it is used for
2. What you need to know before you take Climaval
3. How to take Climaval
4. Possible side effects
5. How to store Climaval
6. Contents of the pack and other information

1. What Climaval is and what it is used for
Climaval is a Hormone Replacement Therapy (HRT). It contains the female hormone oestrogen.
Estradiol valerate is identical to the natural female hormone oestrogen. This hormone is produced by the
ovaries before the menopause.
Climaval is used for:
Relief of symptoms occurring after menopause
Menopause occurs naturally in all women, usually between the ages of 45 and 55 years. It occurs also in
younger women who have their ovaries removed by surgery. During the menopause, the amount of the
oestrogen produced by a woman’s body drops. This can cause symptoms such as hot face, neck and chest
(“hot flushes”), sleep problems, irritability, and depression. Some women also have problems with urine control
or dryness of the vagina, which may cause discomfort during or after sexual intercourse. Climaval alleviates
these symptoms after menopause. You will only be prescribed Climaval if your symptoms seriously hinder your
daily life.

2. What you need to know before you take Climaval
Medical history and regular check-ups
The use of HRT carries risks which need to be considered when deciding whether to start taking it, or whether
to carry on taking it.
The experience in treating women with a premature menopause (due to ovarian failure or surgery) is limited. If
you have a premature menopause the risks of using HRT may be different.
Please talk to your doctor.
Before you start (or restart) Climaval, your doctor will ask about your own and your family’s medical history.
Your doctor may decide to perform a physical examination. This may include an examination of your breasts
and/or an internal examination, if necessary. He/she should tell you what kind of changes in the breast you
should look out for and may advise you to have a breast X-ray (a mammogram). Once you have started on
Climaval, you should see your doctor for regular check-ups (at least once a year). At these check-ups, discuss
with your doctor the benefits and risks of continuing with Climaval.
Go for regular breast screening, as recommended by your doctor.
Do not take Climaval
If any of the following applies to you. If you are not sure about any of the points below, talk to your doctor
before taking Climaval,
• if you have or have ever had breast cancer, or if you are suspected of having it;
• if you have cancer which is sensitive to oestrogens, such as cancer of the womb lining
(endometrium), or if you are suspected of having it;
• if you have any unexplained vaginal bleeding;
• if you have excessive thickening of the womb lining (endometrial hyperplasia) that is not being
treated;
• if you have severe kidney disease;
• if you have or have ever had a blood clot in a vein (thrombosis), such as in the legs (deep venous
thrombosis), or the lungs (pulmonary embolism);
• if you have a blood clotting disorder (such as protein C, protein S or antithrombin deficiency);
• if you have or recently have had a disease caused by blood clots in the arteries, such as a heart
attack, stroke or angina;
• if you have or have ever had a liver disease and your liver function tests have not returned to
normal;
• if you have a rare blood problem called “porphyria” which is passed down in families (inherited);
• if you are allergic (hypersensitive) to oestradiol valerate or any of the other ingredients of Climaval
(listed in section 6);
If any of the above conditions appear for the first time while taking Climaval, stop taking it at once and consult
your doctor immediately.
When to take special care with Climaval
Tell your doctor if you have ever had any of the following problems, before you start the treatment, as
these may return or become worse during treatment with Climaval. If so, you should see your doctor more
often for check-ups.
• Fibroids inside your womb
• Growth of womb lining outside your womb (endometriosis) or a history of excessive growth of the
womb lining (endometrial hyperplasia)
• Increased risk of developing blood clots (see “Blood clots in a vein (thrombosis)”)
• Increased risk of getting an oestrogen-sensitive cancer (such as having a mother, sister or
grandmother who has had breast cancer)
• High blood pressure
• A liver disorder, such as a benign liver tumour (liver adenoma)
• Diabetes
• Gallstones
• Migraine or severe headaches
• A disease of the immune system that affects many organs of the body (Systemic lupus
erythematosus, SLE), an autoimmune disorder
• Epilepsy
• Asthma
• A disease affecting the eardrum and hearing (otosclerosis)
• A very high level of fat in your blood (triglycerides)
• Fluid retention due to cardiac or kidney problems
• Hypothyroidism (a condition in which your thyroid gland fails to produce enough thyroid hormone
and for which you are treated with thyroid hormone replacement therapy)
• Hereditary angioedema or episodes of rapid swelling of the hands, feet, face,
lips, eyes, tongue,
©[´ÐC
throat (airway blockage) or digestive tract.
Stop taking Climaval and see a doctor immediately.

Pg 2 !

DT

Q.A.
APPROVED:

CUSTOMER
APPROVED:

30/10/12

DATE:

DATE:

CUSTOMER: Waymade

PRE-PRESS NO.:

02-1808

PRODUCT:

climaval 2mg tabs

ARTWORKER:

CODE:

6464/2013G

DATE OF PROOF:

PROOF HISTORY:
v.1 - waymade - 30/10/12

\(ÃEè7
Leaflet Flat Size = 296 x 420
ARIAL REGULAR FONT SIZE 8
ARIAL BOLD FONT SIZE 10
BRIDGED TO
TRANSTEC 6464/2327 2328 2329

UK PIL DATED JANUARY 2012

Pg 2

If you notice any of the following when taking HRT:
– Any of the conditions mentioned in the ‘Do Not take Climaval’ section
– Yellowing of your skin or the whites of your eyes (jaundice). These may be signs of a liver disease
– A large rise in your blood pressure (symptoms may be headache, tiredness, dizziness)
– Migraine-like headaches which happen for the first time, with or without disturbed vision.
Headaches like these can be an early sign of a stroke. If you have already had a stroke, talk with your
doctor about whether the benefits of the treatment outweigh the possibly increased risk.
– If you get pain in your chest that spreads to your arm or neck. This pain may be a sign of heart disease.
− If you notice signs of a blood clot, such as:
• painful swelling and redness of the legs
• sudden chest pain
• difficulty in breathing
For more information, see ‘Blood clots in a vein (thrombosis)’.
HRT and cancer
Excessive thickening of the lining of the womb (endometrial hyperplasia) and cancer of the lining of
the womb (endometrial cancer)
Taking oestrogen-only HRT will increase the risk of excessive thickening of the lining of the womb
(endometrial hyperplasia) and cancer of the womb lining (endometrial cancer).
Taking a progestogen in addition to the oestrogen for at least 12 days of each 28 day cycle protects you from
this extra risk. So your doctor will prescribe a progestogen separately if you still have your womb. If you have
had your womb removed (a hysterectomy), discuss with your doctor whether you can safely take this product
without a progestogen.
In women who still have a womb and who are not taking HRT, on average, 5 in 1000 will be diagnosed with
endometrial cancer between the ages of 50 and 65.
For women aged 50 to 65 who still have a womb and who take oestrogen-only HRT, between 10 and 60
women in 1000 will be diagnosed with endometrial cancer (i.e. between 5 and 55 extra cases), depending on
the dose and for how long it is taken.
Unexpected bleeding
You will have a bleed once a month (so-called withdrawal bleed) while taking Climaval. But, if you have
unexpected bleeding or drops of blood (spotting) besides your monthly bleeding, which:
– carries on for more than the first 6 months
– starts after you have been taking Climaval for more than 6 months
– carries on after you have stopped taking Climaval
– if you have painful menstrual periods

Pg 3

Other conditions
HRT will not prevent memory loss. There is some evidence of a higher risk of memory loss in women who start
using HRT after the age of 65. Speak to your doctor for advice.
Taking other medicines
Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including
medicines obtained without a prescription, herbal medicines or other natural products. Some medicines may
interfere with the effect of Climaval. This might lead to irregular bleeding. This applies to the following
medicines:
• medicines for epilepsy (such as phenobarbital, phenytoin, carbamazepine),
• medicines for tuberculosis (such as rifampicin, rifabutin),
• medicines for HIV infection (such as nevirapine, efavirenz, ritonavir, nelfinavir),
• herbal remedies containing St John’s Wort (Hypericum perforatum).
Laboratory tests
If you need a blood test, tell your doctor or the laboratory staff that you are taking Climaval, because this
medicine can affect the results of some tests.
Pregnancy and breast-feeding
Not applicable, because Climaval is only indicated in women without a uterus.
Driving and using machines
Climaval has no known effects on the ability to drive and use machines.
Climaval contains lactose
Lactose is a form of sugar. If you have been told by your doctor that you have an intolerance to some sugars,
contact your doctor before taking Climaval.

3. How to take Climaval
Always use Climaval exactly as your doctor has told you. Your doctor will aim to prescribe the lowest dose to
treat your symptom for as short as necessary. Speak to your doctor if you think this dose is too strong or not
strong enough. During the treatment your doctor may adjust the dose according to your individual needs.
When to start treatment
• If you are currently not using any form of HRT (patches or tablets), or if you have been using a
continuous combined HRT product (where oestrogen and the progestogen are given every day
without interruption), you can start to use Climaval on any convenient day.


See your doctor as soon as possible.

If you are changing from a cyclic or sequential HRT treatment (where the progestogen is added
for 12-14 days of the cycle), you should start to use Climaval on the day after you complete your
previous cycle.

How to take Climaval
Take one tablet each day by following the sequence of numbers and arrows on the calendar pack.

Breast cancer
Evidence suggests that taking combined oestrogen-progestogen and possibly also oestrogen-only HRT
increases the risk of breast cancer. The extra risk depends on how long you take HRT.
The additional risk becomes clear within a few years.
However, it returns to normal within a few years (at most 5) after stopping treatment.

Swallow your tablets whole with a glass of water.

For women who have had their womb removed and who are using oestrogen-only HRT for 5 years, little or no
increase in breast cancer risk is shown.
Compare
Women aged 50 to 79 who are not taking HRT, on average, 9 to 14 in 1000 will be diagnosed with breast
cancer over a 5-year period. For women aged 50 to 79 who are taking oestrogen-progestogen HRT over 5
years, there will be 13 to 20 cases in 1000 users (i.e. an extra 4 to 6 cases).

The pack has been designed specifically to help you take the tablets correctly.
Write the name of the day you take your first tablet in the box below and in the box on the carton. For example,
if you start your tablets on a Wednesday, then write “Wednesday” in the boxes.
This day will also be the day on which you will take tablets 8, 15 and 22. This will help you check that you
have taken each tablet on the right day.
Write your start day here:
When you finish one blister pack, start the new one the next day whether or not you experience bleeding. This
will normally be the same day of the week as you started the previous blister pack. Do not take a break
between blister packs unless your doctor tells you to.

Regularly check your breasts. See your doctor if you notice any changes such as:
• dimpling of the skin
• change in the nipple
• any lump you can see or feel
Ovarian cancer
Ovarian cancer is rare. A slightly increased risk of ovarian cancer has been reported in women taking HRT for
at least 5 to 10 years.
Women aged 50 to 69 who are not taking HRT, on average about 2 women in 1000 will be diagnosed with
ovarian cancer over a 5-year period. For women who have been taking HRT for 5 years, there will be between
2 and 3 cases per 1000 users (i.e. up to 1 extra case).
Effect of HRT on heart and circulation
Blood clots in a vein (thrombosis)
The risk of blood clots in the veins is about 1.3 to 3- times higher in HRT users than in non-users, especially
during the first year of taking it.
Blood clots can be serious, and if one travels to the lungs, it can cause chest pain, breathlessness, fainting or
even death.
You are more likely to get a blood clot in your veins as you get older and if any of the following applies to you.
Inform your doctor if any of these situations applies to you:
• you are unable to walk for a long time because of major surgery, injury or illness (see also section 3,
If you need to have surgery)
• you are seriously overweight (BMI >30 kg/m2)
• you have any blood clotting problem that needs long-term treatment with a medicine used to prevent
blood clots
• if any of your close relatives has ever had a blood clot in the leg, lung or an other organ
• you have systemic lupus erythematosus (SLE)
• you have cancer.
For signs of a blood clot, see “Stop taking Climaval and see a doctor immediately”.
Compare
Looking at women in their 50s who are not taking HRT, on average, over a 5-year period, 4 to 7 in 1000 would
be expected to get a blood clot in a vein.
For women in their 50s who have been taking oestrogen-progestogen HRT for over 5 years, there will be 9 to
12 cases in 1000 users (i.e. an extra 5 cases).
For women in their 50s who have had their womb removed and have been taking oestrogen-only HRT for over
5 years, there will be 5 to 8 cases in 1000 users (i.e. 1 extra case).
Heart disease (heart attack)
There is no evidence that HRT will prevent a heart attack.
Women over the age of 60 years who use oestrogen-progestogen HRT are slightly more likely to develop
heart disease than those not taking any HRT.

The tablets are best taken at the same time every day; try to get into a routine.
Follow your doctor’s instructions as to how and when you should take Climaval tablets and never change the
dose yourself, however well you feel.
If you are unsure about how much medicine to take or when to take it ask your doctor or pharmacist.
How long to take Climaval
From time to time, you will need to discuss with your doctor the possible risks and benefits associated with
Climaval and whether you still need the treatment. It is important that you take the lowest possible effective
dose and only as long as needed.
If you have taken more Climaval than you should
Contact your doctor of pharmacist immediately if you have taken too much Climaval.
If you forget to take Climaval
If you forget to take a tablet at your usual time, try to take it within 12 hours. If this is not possible, leave the
forgotten tablet and continue to take the remaining tablets at the usual time.
If you need to have surgery
If you are going to have surgery, tell the surgeon that you are taking Climaval. You may need to stop taking
Climaval about 4 to 6 weeks before the operation to reduce the risk of a blood clot (see section 2, Blood clots
in a vein). Ask your doctor when you can start taking Climaval again.
If you stop taking Climaval
Stopping Climaval may increase the risk of breakthrough bleeding or spotting. If this occurs after you stop
treatment, contact your doctor immediately. Your doctor will need to work out the reason for this.
After a long treatment break, consult your doctor before starting to use Climaval again.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects
The following diseases are reported more often in women using HRT compared to women not using HRT:
• breast cancer
• abnormal growth or cancer of the lining of the womb (endometrial hyperplasia or cancer)
• ovarian cancer
• blood clots in the veins of the legs or lungs (venous thromboembolism)
• heart disease
• stroke
• probable memory loss if HRT is started over the age of 65
For more information about these side effects, see Section 2.

For women who have had their womb removed and are taking oestrogen-only therapy there is no increased
risk of developing a heart disease.
Stroke
The risk of getting stroke is about 1.5 times higher in HRT users than in non-users.
The number of extra cases of stroke due to use of HRT will increase with age.

©[´ÐC

Compare
Looking at women in their 50s who are not taking HRT, on average, 8 in 1000 would be expected to have a
stroke over a 5-year period. For women in their 50s who are taking HRT, there will be 11 cases in 1000 users,
over 5 years (i.e. an extra 3 cases).
Pg 3 !

Pg 4 !

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide